Role of activin A in carbon tetrachloride-induced acute liver injury.

AIM To investigate the expression and role of activin A in a mouse model of acute chemical liver injury. METHODS Acute liver injury in C57BL/6 male mice was induced by intraperitoneal injection with carbon tetrachloride (CCl4) (0.5 mL/kg, body weight) dissolved in olive oil (1:19 v/v). Mice were sacrificed 1, 3, 5 and 7 d after the treatment. The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum were examined and pathological changes of liver observed by hematoxylin and eosin staining to evaluate the liver injury. Activin A protein levels in serum and hepatic tissue homogenate of mice were detected by enzyme-linked immunosorbent assay, and the expression pattern of activin A protein in livers of mice was examined by immunohistochemistry. Activin type IIA receptor (ActRIIA) and Smad3 expressions in the liver were analyzed by real-time quantitative reverse transcription-polymerase chain reaction. In order to further investigate the role of activin A, we also utilized activin A blocking experiment by anti-activin A antibody (500 μg/kg, body weight) injection into mouse tail vein. RESULTS In CCl4-treated mice, serum ALT and AST levels were significantly increased, compared with that in control mice (P < 0.01). Furthermore, the serious necrosis was observed around hepatic portal areas in CCl4-treated mice. Simultaneously, activin A levels in serum and hepatic tissue homogenate of mice treated with CCl4 for 1, 3 and 5 d increased significantly, compared with that in control mice (P < 0.01). Activin A protein expression in hepatocytes not within the necrotic area was also upregulated in mice following CCl4 treatment. Not only activin A, but also ActRIIA and activin signaling molecule Smad3 mRNA expressions in injury liver induced by CCl4 were significantly higher than that in control liver. In addition, levels of serum ALT and AST in CCl4-treated mice were significantly decreased by injection of anti-activin A antibody to block endogenous activin A action, compared with that in CCl4-treated mice by injection of immunoglobulin G instead of anti-activin A antibody (P < 0.01), and the severity of liver injury was also reduced remarkably. CONCLUSION These data show that activin A is involved in CCl4-induced acute liver injury. Blocking activin A actions may be a therapeutic approach for acute liver injury.

[1]  X. Cui,et al.  Localisation and Role of Activin Receptor‐Interacting Protein 1 in Mouse Brain , 2013, Journal of neuroendocrinology.

[2]  Zhonghui Liu,et al.  The role and mechanism of action of activin A in neurite outgrowth of chicken embryonic dorsal root ganglia , 2012, Journal of Cell Science.

[3]  K. Loveland,et al.  Activin A Balances Sertoli and Germ Cell Proliferation in the Fetal Mouse Testis1 , 2010, Biology of reproduction.

[4]  Omnia A. Mohammed,et al.  Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases , 2010, International journal of rheumatic diseases.

[5]  Suguru Yamada,et al.  Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor , 2010, BMC gastroenterology.

[6]  C. Rivera,et al.  CCl4‐induced hepatic injury in mice fed a Western diet is associated with blunted healing , 2010, Journal of gastroenterology and hepatology.

[7]  D. C. Kim,et al.  Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice. , 2010, Journal of pharmacological sciences.

[8]  Zhonghui Liu,et al.  A Critical Role of Activin A in Maturation of Mouse Peritoneal Macrophages in vitro and in vivo , 2009, Cellular and Molecular Immunology.

[9]  N. Sarvetnick,et al.  Upregulation of activin signaling in experimental colitis. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[10]  G. Ning,et al.  Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis , 2009, Laboratory Investigation.

[11]  Zhonghui Liu,et al.  Expression and localization of activin receptor-interacting protein 2 in mouse tissues. , 2009, General and comparative endocrinology.

[12]  M. Hedger,et al.  Activin and related proteins in inflammation: not just interested bystanders. , 2009, Cytokine & growth factor reviews.

[13]  Zhonghui Liu,et al.  Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. , 2008, Cytokine.

[14]  W. Berger,et al.  Activins and activin antagonists in hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[15]  Zhonghui Liu,et al.  Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV. , 2007, World journal of gastroenterology.

[16]  K. Ogawa,et al.  Activin A Functions as a Th2 Cytokine in the Promotion of the Alternative Activation of Macrophages1 , 2006, The Journal of Immunology.

[17]  Sabine Werner,et al.  Roles of activin in tissue repair, fibrosis, and inflammatory disease. , 2006, Cytokine & growth factor reviews.

[18]  S. Choe,et al.  Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Tsuchida,et al.  Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling. , 2006, The Journal of endocrinology.

[20]  D. Phillips,et al.  Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[21]  G. Risbridger,et al.  βA- and βC-activin, follistatin, activin receptor mRNA and βC-activin peptide expression during rat liver regeneration , 2005 .

[22]  K. Tsuchida,et al.  Novel factors in regulation of activin signaling , 2004, Molecular and Cellular Endocrinology.

[23]  R. Nau,et al.  Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. , 2003, European journal of endocrinology.

[24]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[25]  Mark Cranfield,et al.  Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis , 2003, Molecular and Cellular Endocrinology.

[26]  K. Matsuzaki,et al.  Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. , 2000, Journal of hepatology.

[27]  Y. Sakamoto,et al.  Effects of LHRH, FSH and activin A on follistatin secretion from cultured rat anterior pituitary cells. , 1996, Endocrine journal.

[28]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[29]  J. Vaughan,et al.  Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures , 1990, Cell.